@article{article, title = {{Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial}}, publisher = {{Elsevier BV}}, url = {{http://eprints.whiterose.ac.uk/165266/ }}, year = {{2020}}, month = {{7}}, author = {{Simpson EL and Sinclair R and Forman S and Wollenberg A and Aschoff R and Cork M and Bieber T and Thyssen JP and Yosipovitch G and Flohr C and Magnolo N et al}}, doi = {{10.1016/s0140-6736(20)30732-7}}, volume = {{396}}, journal = {{The Lancet}}, issue = {{10246}}, pages = {{255-266}}, note = {{Accessed on 2024/12/22}}}